- 1,310studies, of 27,380 in the library
- 1,310peer-reviewed
- 2005–2026years published
- 49median usefulness score out of 100
These counts and lists are worked out from the library itself each time the page loads. A score rates how much weight a study can bear — its design, journal, evidence and recency — not whether its result is good news.
How the records spell this journal (3 spellings)
- Alzheimer s & Dementia — 565 studies
- Alzheimer's & dementia : the journal of the Alzheimer's Association — 699 studies
- Alzheimer's & Dementia — 46 studies
The 20 highest-scoring
- Donanemab in preclinical Alzheimer's disease: Screening and baseline data from TRAILBLAZER-ALZ 3
- Safety, tolerability, immunogenicity, and efficacy of ABvac40 active immunotherapy against Aβ40 in patients with mild cognitive impairment or very mild Alzheimer's disease: A randomized, double-blind, placebo-controlled phase 2 study
- Japanese participant data from three gantenerumab trials in early Alzheimer's disease
- An 18-month multimodal intervention trial for preventing dementia: J-MINT PRIME Tamba
- TRAILBLAZER-ALZ 4: A phase 3 trial comparing donanemab with aducanumab on amyloid plaque clearance in early, symptomatic Alzheimer's disease
- Alzheimer's blood-based biomarkers, incident dementia, and interactions with age, APOE status, and hormone therapy
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Associations of inner retinal layers with risk of incident dementia: An individual participant data analysis of four prospective cohort studies
- A phase 2, randomized, multicenter, double-blind, placebo-controlled trial of S-adenosyl methionine in participants with mild cognitive impairment or dementia due to Alzheimer's disease
- Japan-Multimodal Intervention Trial for the Prevention of Dementia: A randomized controlled trial
- CSF biomarker concordance with amyloid PET in Phase 3 studies of aducanumab
- A phase-II randomized controlled pilot study of nicotinamide riboside supplementation in older adults with amnestic mild cognitive impairment
- Alzheimer's disease genetic risk score and neuroimaging in the FINGER lifestyle trial
- Polysomnographic assessment of suvorexant in patients with probable Alzheimer's disease dementia and insomnia: a randomized trial
- Effects of a multidomain intervention against cognitive decline on dementia risk profiles - Results from the AgeWell.de trial
- Results from the long-term extension of PRIME: A randomized Phase 1b trial of aducanumab
- The relationship of soluble tau species with Alzheimer's disease amyloid plaque removal and tau pathology
- Effects of the SGLT2 inhibitor dapagliflozin in early Alzheimer's disease: A randomized controlled trial
- A multidomain intervention against cognitive decline in an at-risk-population in Germany: Results from the cluster-randomized AgeWell.de trial
- The effect of adherence on cognition in a multidomain lifestyle intervention (FINGER)
See all 1,310 studies, with filters →
Newest additions
- Sex-specific brain reserve and progression from mild cognitive impairment to Alzheimer's disease dementia
- Tau extent is associated with lower cognition in Down syndrome-related Alzheimer's disease
- TMEM106B is a selective modulator of TDP-43 pathology in Alzheimer's disease
- Brain-derived plasma p-tau217 shows enhanced dynamic range for Alzheimer's disease neuropathological change
- Digital cognitive phenotyping enhances risk stratification in preclinical Alzheimer's disease
- Psychological impacts of APOE genotype disclosure among Latinos in New York City: a randomized controlled trial
- Changes in serum β-synuclein precede blood biomarkers of Alzheimer pathology in Down syndrome
- Plasma P-tau217 for detecting amyloid clearance after donanemab in Alzheimer's disease
- Plasma p-tau217 detects Alzheimer's disease co-pathology in cerebral amyloid angiopathy: Comparison to CSF biomarkers in the ANGMAR cohort
- APOE-guided lecanemab dosing dissociates ARIA-E from ARIA-H: The K-ROAD study
From across this list
10 of the 1,291 studies in this list, picked by a fixed rule (a hash of each study's address), not by score or date. The same 10 appear here every time.
- Analytical and clinical validation of the Lumipulse G plasma p-tau217 assay for clinical implementation
- Real-world lecanemab adoption in Japan 1 year after launch: Insights from 311 specialists on infrastructure and reimbursement barriers
- The microbiota-gut-brain axis in mild cognitive impairment and Alzheimer's disease: a scoping review of human studies
- Mediation of modifiable risk factors in two multidomain dementia prevention trials
- Monitoring night‐time safety in households with dementia using ambient sensing technologies: a rule‐based decision algorithm
- Medical and nursing home costs: From cognitively unimpaired through dementia
- Speech-in-noise hearing impairment is associated with an increased risk of incident dementia in 82,039 UK Biobank participants
- Comparison of CSF phosphorylated tau 181 and 217 for cognitive decline
- Identifying gait differences between Alzheimer's disease and dementia with Lewy bodies and their associations with regional amyloid deposition
- Neighborhood Deprivation, Subjective and Objective Cognitive Impairment
By review status
- Peer-reviewed — 1,310